Researchers have developed a method for self-assembling nanostructures with gamma-modified peptide nucleic acid, a synthetic mimic of DNA
Synthetic DNA mimic can assemble novel nanostructures
News
Nanomedicine and Nanotechnology
Cellular decoys distract coronavirus
Wrapping polymer nanoparticles in membranes from human lung epithelial type II cells and immune cells creates a biomimetic system that can act as a decoy for SARS-CoV-2
Gold nanoparticles accelerate individual cancer diagnosis and treatment
Researchers proposed a new method for producing gold nanoparticles based on synthesis under the influence of ultraviolet radiation. The method excludes the use of aggressive chemical agents and the obtained nanoparticles are safe for the body and can be used for the diagnosis and treatment of cancer
Hollow carbon balls hit tumors harder
Hollow carbon loaded with drugs can be given a boost by bombarding them with microwaves and laser irradiation to treat tumors
A remote control for neurons
Researchers created a new technology that enhances scientists’ ability to communicate with neural cells using light
Implantable biosensor that operates without batteries
Researchers from the University of Surrey have revealed their new biodegradable motion sensor – paving the way for implanted nanotechnology that could help future sports professionals better monitor their movements to aid rapid improvements, or help caregivers remotely monitor people living with dementia
Researchers tap CRISPR technology to connect biology, electronics
Technique, published in Nature Communications, has the potential to further bridge the gap between the electronic and biological worlds, paving the way for new wearable and “smart” devices
Nanotechnology to identify patients most at risk from COVID-19
In a new paper researchers proposed a point-of-care diagnostic platform that uses either nanoparticles or magnetic levitation to diagnose infection and assess future risk
Plant virus-like particles as vehicles for therapeutic antibodies
Researchers have developed a Virus-Like Particles (VLP) of a plant virus to use as a possible vehicle to deliver antibodies into a cell. These VLPs can enter mammalian cells, despite being of plant origin